A Practice Note providing an overview of the types of remedies the federal antitrust agencies use to preserve competition post-merger. This Note discusses the agencies' use of structural remedies such as divestitures, licenses and asset swaps, and behavioral remedies, such as non-discrimination and fair dealing provisions, mandatory licensing provisions, and anti-retaliation provisions. This Note discusses how the agencies and merging parties negotiate remedies, best practices, and the review process at each agency.